Evidence map›Paper›PMID 34979405›Full record

ArticleComputers in biology and medicine2022

Computational modelling of potentially emerging SARS-CoV-2 spike protein RBDs mutations with higher binding affinity towards ACE2: A structural modelling study.

Abbas Khan, Sarfaraz Hussain, Sajjad Ahmad, Muhammad Suleman, Imrana Bukhari, Taimoor Khan, Farooq Rashid, Abul Kalam Azad, Muhammad Waseem, Wajid Khan and 5 more

Open access · greenAbstract read
In one paragraph

Article in Computers in biology and medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.4field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Allosteric control of ACE2 peptidase domain dynamics.Organic & biomolecular chemistry · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 9 institutions in 3 countries.

Abbas KhanDepartment of Bioinformatics and Biological Statistics, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, 200240, PR China.
Sarfaraz HussainInstitute of Food Sciences and Technology, Chinese Academy of Agriculture Sciences, Beijing, 100193, China.
Sajjad AhmadDepartment of Health and Biological Sciences, Abasyn University, Peshawar, 25000, Pakistan.
Muhammad SulemanCenter for Biotechnology and Microbiology, University of Swat, Swat, KP, Pakistan.
Imrana BukhariDepartment of Botany, University of Okara, Punjab, Pakistan.
Taimoor KhanDepartment of Bioinformatics and Biological Statistics, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, 200240, PR China.
Farooq RashidSchool of Public Health, Department of Epidemiology, Southern Medical University, Dermatology Hospital, Guangzhou, China.
Abul Kalam AzadAdvanced Drug Delivery Laboratory, Department of Pharmaceutical Technology, Faculty of Pharmacy, International Islamic University Malaysia, 25200, Kuantan, Pahang, Malaysia.
Muhammad WaseemFaculty of Rehabilitation and Allied Health Science, Riphah International University, Islamabad, Pakistan.
Wajid KhanCenter for Biotechnology and Microbiology, University of Swat, Swat, KP, Pakistan.
Zahid HussainCenter for Biotechnology and Microbiology, University of Swat, Swat, KP, Pakistan.
Asghar KhanSaidu Teaching Hospital, Saidu Sharif, Swat, Khyber Pakhtunkhwa, Pakistan.
Syed Shujait AliCenter for Biotechnology and Microbiology, University of Swat, Swat, KP, Pakistan.
Qiyao QinSchool of Statistics, Renmin University of China, PR China.
Dong-Qing WeiDepartment of Bioinformatics and Biological Statistics, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, 200240, PR China; Peng Cheng Laboratory, Vanke Cloud City Phase I Building 8, Xili Street, Nashan District, Shenzhen, Guangdong, 518055, PR China; State Key Laboratory of Microbial Metabolism, Shanghai-Islamabad-Belgrade Joint Innovation Center on Antibacterial Resistances, Joint Laboratory of International Cooperation in Metabolic and Developmental Sciences, Ministry of Education and School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, 200030, PR China. Electronic address: dqwei@sjtu.edu.cn.
Shanghai Jiao Tong University · CNUniversity of Swat · PKAbasyn University · PKInstitute of Food Science and Technology · CNInternational Islamic University Malaysia · MYRenmin University of China · CNRiphah International University · PKSouthern Medical University · CNUniversity of Okara · PK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The spike protein of SARS-CoV-2 and the host ACE2 receptor plays a vital role in the entry to the cell. Among which the hotspot residue 501 is continuously subjected to positive selection pressure and induces unusual virulence. Keeping in view the importance of the hot spot residue 501, we predicted the potentially emerging structural variants of 501 residue. We analyzed the binding pattern of wild type and mutants (Spike RBD) to the ACE2 receptor by deciphering variations in the amino acids' interaction networks by graph kernels along with evolutionary, network metrics, and energetic information. Our analysis revealed that N501I, N501T, and N501V increase the binding affinity and alter the intra and inter-residue bonding networks. The N501T has shown strong positive selection and fitness in other animals. Docking results and repeated simulations (three times) confirmed the structural stability and tighter binding of these three variants, correlated with the previous results following the global stability trend. Consequently, we reported three variants N501I, N501T, and N501V could worsen the situation further if they emerged. The relations between the viral fitness and binding affinity is a complicated game thus the emergence of high affinity mutations in the SARS-CoV-2 RBD brings up the question of whether or not positive selection favours these mutations or not?

Indexed as

Spike Glycoprotein, CoronavirusAngiotensin-Converting Enzyme 2AnimalsCOVID-19HumansMolecular Dynamics SimulationMutationProtein BindingProtein DomainsSARS-CoV-2Angiotensin-Converting Enzyme 2Spike Glycoprotein, Coronavirusspike protein, SARS-CoV-2Emerging variantsFree energyModelingSARS-CoV-2Simulation

Identifiers

PMID34979405
PMCPMC8716154
OpenAlexW4200538861

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.